Goodwin Daniel L Actinium Pharmaceuticals, Inc. Transaction History

Goodwin Daniel L

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$4.57 - $6.4 $45,700 - $64,000	-10,000 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$7.01 - $8.63 $70,100 - $86,300	-10,000 Reduced 50.0%	10,000 $80,000
Q4 2020 Jan 25, 2021	BUY	$7.8 - $12.64 $156,000 - $252,800	20,000 New	20,000 $156,000

8.31M

65.2K

21.7K

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $30.7M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

Get notified when there are updates to the investment portfolio of Goodwin Daniel L, based on Form 13F filings with the SEC.

Stay updated on Goodwin Daniel L with notifications on news.